Autoantibodies against Folate Receptors in Women with a Pregnancy Complicated by a Neural-Tube Defect

New England Journal of Medicine

Volumn 350, Issue 2, 2004, Pages 134-142

  Rothenberg, Sheldon P ^a   Da Costa, Maria P ^a   Sequeira, Jeffrey M ^a   Cracco, Joan ^a   Roberts, Jaclyn L ^a   Weedon, Jeremy ^a   Quadros, Edward V ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; FOLATE RECEPTOR; FOLIC ACID; RECEPTOR; RECEPTOR ANTIBODY; TRITIUM; UNCLASSIFIED DRUG;

ADULT; ANTIGEN BINDING; ARTICLE; CELL STRAIN; CELL STRAIN KB; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG UPTAKE; FEMALE; FETUS; HUMAN; HUMAN CELL; HUMAN TISSUE; INCUBATION TIME; ISOTOPE LABELING; NEURAL TUBE DEFECT; NONHUMAN; NULLIPARA; PLACENTA; PREGNANCY; PREGNANCY COMPLICATION; PRIMIGRAVIDA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; SERUM; TEMPERATURE; VITAMIN SUPPLEMENTATION;

ADULT; AUTOANTIBODIES; CARRIER PROTEINS; CASE-CONTROL STUDIES; CELL LINE; FEMALE; FOLIC ACID; HUMANS; KB CELLS; NEURAL TUBE DEFECTS; PLACENTA; PREGNANCY; RECEPTORS, CELL SURFACE;

EID: 0347988053     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa031145     Document Type: Article

References (27)

1. Cragan JD, Roberts HE, Edmonds LD, et al. Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis - United States, 1985-1994. MMWR CDC Surveill Summ 1995;44(4):1-13.
2. Czeizel AE, Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5.
3. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991;338:131-7.
4. Giles C. An account of 335 cases of megaloblastic anaemia of pregnancy and the puerperium. J Clin Pathol 1966;19:1-11.
5. Christensen B, Arbour L, Tran P, et al. Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet 1999;84:151-7.
6. Antony AC. Folate receptors. Annu Rev Nutr 1996;16:501-21.
7. Piedrahita JA, Oetama B, Bennett GD, et al. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nat Genet 1999;23:228-32.
8. Finnell RH, Wlodarczyk B, Speigelstein O, Triplett A, Gelineau-vanWaes J. Folate transport abnormalities and congenital defects. In: Milstien S, Kapatos G, Levine RA, Shane B, eds. Chemistry and biology of pteridines and folates. Boston: Kluwer Academic. 2002:637-42.
9. Barber RC, Shaw GM, Lammer EJ, et al. Lack of association between mutations in the folate receptor-alpha gene and spina bifida. Am J Med Genet 1998;76:310-7. [Erratum, Am J Med Genet 1998;79:231.]
10. Barber RC, Shaw GM, Lammer EJ, et al. Lack of association between mutations in the folate receptor-alpha gene and spina bifida. Am J Med Genet 1998;76:310-7. [Erratum, Am J Med Genet 1998;79:231.]
11. da Costa M, Rothenberg SP. Purification and characterization of folate binding proteins from rat placenta. Biochim Biophys Acta 1996;1292:23-30.
12. da Costa M, Sequeira JM, Rothenberg SP, Weedon J. Antibodies to folate receptors impair embryogenesis and fetal development in the rat. Birth Defects Res A Clin Mol Teratol 2003;67:837-47.
13. Sadasivan E, da Costa M, Rothenberg SP, Brink L. Purification, properties, and immunological characterization of folate-binding proteins from human leukemia cells. Biochim Biophys Acta 1987;925:36-47.
14. Kniss DA, Xie Y, Lin Y, et al. ED(27) trophoblast-like cells isolated from first-trimester chorionic villi are genetically identical to HeLa cells yet exhibit a distinct phenotype. Placenta 2002;23:32-43.
15. McHugh M, Cheng YC. Demonstration of a high affinity folate binder in human cell membranes and its characterization in cultured human KB cells. J Biol Chem 1979;254:11312-8.
16. Scatchard G. The attractions of proteins for small molecules and ions. Ann N Y Acad Sci 1949;51:660-72.
17. Hernández-Diaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000;343:1608-14.
18. Dansky LV, Rosenblatt DS, Andermann E, Mechanisms of teratogenesis: folic acid and antiepileptic therapy. Neurology 1992;42:Suppl 5:32-42.
19. Seller MJ. Neural tube defects, chromosome abnormalities and multiple closure sites for the human neural tube. Clin Dysmorphol 1995;4:202-7.
20. Finnell RH, Gelineau-van Waes J, Bennett GD, et al. Genetic basis of susceptibility to environmentally induced neural tube defects. Ann N Y Acad Sci 2000;919:261-77.
21. De Marco P, Moroni A, Merello E, et al. Folate pathway gene alterations in patients with neural tube defects. Am J Med Genet 2000;95:216-23.
22. Antony AC, Hansen DK. Hypothesis: folate-responsive neural tube defects and neurocristopathies. Teratology 2000;62:42-50.
23. Henderson GB. Folate-binding proteins. Annu Rev Nutr 1990;10:319-35.
24. Evans DR. Neural-tube defects: importance of a history of abortion in aetiology. Br Med J 1979;1:975-6.
25. Carmi R, Gohar J, Meizner I, Katz M. Spontaneous abortion - high risk factor for neural tube defects in subsequent pregnancy. Am J Med Genet 1994;51:93-7.
26. Cuckle HS. Recurrence risk of neural tube defects following a miscarriage. Prenat Diagn 1983;3:287-9.
27. Wilcox AJ, Weinberg CR, O'Connor JF, et al. Incidence of early loss of pregnancy. N Engl J Med 1988;319:189-94.